These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 1659573

  • 1. In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion.
    Ossowski L, Clunie G, Masucci MT, Blasi F.
    J Cell Biol; 1991 Nov; 115(4):1107-12. PubMed ID: 1659573
    [Abstract] [Full Text] [Related]

  • 2. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.
    Zhu F, Jia S, Xing G, Gao L, Zhang L, He F.
    DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166
    [Abstract] [Full Text] [Related]

  • 3. Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding.
    Quax PH, Grimbergen JM, Lansink M, Bakker AH, Blatter MC, Belin D, van Hinsbergh VW, Verheijen JH.
    Arterioscler Thromb Vasc Biol; 1998 May; 18(5):693-701. PubMed ID: 9598826
    [Abstract] [Full Text] [Related]

  • 4. Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor.
    Olson D, Pöllänen J, Høyer-Hansen G, Rønne E, Sakaguchi K, Wun TC, Appella E, Danø K, Blasi F.
    J Biol Chem; 1992 May 05; 267(13):9129-33. PubMed ID: 1315748
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ, Lee SW, Dichek DA, Ellis V.
    J Pept Sci; 2000 Sep 05; 6(9):432-9. PubMed ID: 11016879
    [Abstract] [Full Text] [Related]

  • 8. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug 05; 48(8):623-32. PubMed ID: 8808830
    [Abstract] [Full Text] [Related]

  • 9. Characterization of cell-associated plasminogen activation catalyzed by urokinase-type plasminogen activator, but independent of urokinase receptor (uPAR, CD87).
    Longstaff C, Merton RE, Fabregas P, Felez J.
    Blood; 1999 Jun 01; 93(11):3839-46. PubMed ID: 10339491
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase.
    Ossowski L.
    J Cell Biol; 1988 Dec 01; 107(6 Pt 1):2437-45. PubMed ID: 2848851
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy.
    Kook YH, Adamski J, Zelent A, Ossowski L.
    EMBO J; 1994 Sep 01; 13(17):3983-91. PubMed ID: 8076594
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro anti-proliferative and anti-invasive role of aminoterminal fragment of urokinase-type plasminogen activator on 8701-BC breast cancer cells.
    Luparello C, Del Rosso M.
    Eur J Cancer; 1996 Apr 01; 32A(4):702-7. PubMed ID: 8695276
    [Abstract] [Full Text] [Related]

  • 17. Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function.
    Fischer K, Lutz V, Wilhelm O, Schmitt M, Graeff H, Heiss P, Nishiguchi T, Harbeck N, Kessler H, Luther T, Magdolen V, Reuning U.
    FEBS Lett; 1998 Oct 30; 438(1-2):101-5. PubMed ID: 9821967
    [Abstract] [Full Text] [Related]

  • 18. Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro.
    Stahl A, Mueller BM.
    Cancer Res; 1994 Jun 01; 54(11):3066-71. PubMed ID: 8187097
    [Abstract] [Full Text] [Related]

  • 19. Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA). Inhibition of proliferation and invasion of human ovarian cancer cells.
    Wilhelm O, Weidle U, Höhl S, Rettenberger P, Schmitt M, Graeff H.
    FEBS Lett; 1994 Jan 10; 337(2):131-4. PubMed ID: 8287966
    [Abstract] [Full Text] [Related]

  • 20. Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-alpha or basic fibroblast growth factor.
    Mori T, Abe T, Wakabayashi Y, Hikawa T, Matsuo K, Yamada Y, Kuwano M, Hori S.
    J Neurooncol; 2000 Jan 10; 46(2):115-23. PubMed ID: 10894364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.